ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

CTXR Citius Pharmaceuticals Inc

0.7011
0.00 (0.00%)
Pre Market
Last Updated: 05:22:11
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Sep 2021Dec 2021Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 000003.59M00
Operating Income -5.2M-9.26M-13.45M-7.25M-10.69M-5.09M-10.13M-9.34M
Pre Tax Income -3.51M-9.23M-13.32M-3.45M-10.38M-8.34M-9.8M-9.09M
Net Income -3.51M-9.23M-13.89M-3.59M-10.24M-8.77M-11.1M-9.23M
Preferred Dividends 000000-1.15M0
Basic Earnings Per Share (EPS) 00000000
EBIT -5.04M-9.26M-13.45M-3.67M-10.69M-5.09M-6.54M-9.34M
EBITDA -5.33M-9.26M-13.58M-7.2M-10.73M-4.94M-10.27M-9.34M
Year End September 29 2023 20162017201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 00000000
Operating Income -7.45M-9.99M-13.79M-15.6M-17.71M-23.53M-39.22M-36.73M
Pre Tax Income -8.3M-10.39M-12.54M-15.56M-17.55M-23.05M-38.97M-31.97M
Net Income -8.3M-10.39M-12.54M-15.56M-17.55M-23.05M-39.54M-33.69M
Preferred Dividends 0000000-1.15M
Basic Earnings Per Share (EPS) -0.243-2.13-1.502-0.538-0.316-0.158-0.271-0.212
EBIT -7.45M-9.99M-12.52M-15.6M-17.6M-23.31M-39.22M-33.15M
EBITDA -7.45M-9.98M-13.79M-15.6M-17.71M-23.53M-39.21M-36.73M

Your Recent History

Delayed Upgrade Clock